Cost of popular new weight-loss drugs could bankrupt some companies, Blackstone chief warns
At a health care conference, executives debated whether employers should pay for workers’ weight-loss drugs. A Blackstone executive warned that expensive GLP-1 drugs could put some employers out of business. Panelists agreed that companies covering drugs should do so as part of a broader support program. Loading Something is loading. Thanks for recording! Access your …